| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.7M | +89.3% |
| SG&A Expense | $7.2M | +121.2% |
| Operating Income | -$14.9M | -103.4% |
| Interest Expense | $2.8M | +7016.7% |
| Pre-tax Income | -$18.6M | -152.6% |
| Income Tax | $2K | +0.0% |
| Net Income | -$18.6M | -152.5% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.1M | +518.1% |
| Current Assets | $9.4M | +469.4% |
| Total Assets | $9.8M | +338.0% |
| Current Liabilities | $970K | -70.6% |
| Total Liabilities | $1.0M | -71.3% |
| Stockholders' Equity | $8.8M | +793.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | -73.6% |
| Capital Expenditures | $55K | -50.1% |
| Investing Cash Flow | -$55K | +50.1% |
| Financing Cash Flow | $17.9M | +310.6% |
| Free Cash Flow | -$10.3M | -71.4% |